Logo image of CELU

CELULARITY INC-A (CELU) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CELU - US1511902041 - Common Stock

1.32 USD
+0.01 (+0.76%)
Last: 1/20/2026, 4:30:00 PM
Fundamental Rating

1

Overall CELU gets a fundamental rating of 1 out of 10. We evaluated CELU against 525 industry peers in the Biotechnology industry. CELU may be in some trouble as it scores bad on both profitability and health. CELU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CELU had negative earnings in the past year.
  • CELU had a negative operating cash flow in the past year.
  • CELU had negative earnings in 4 of the past 5 years.
  • In the past 5 years CELU always reported negative operating cash flow.
CELU Yearly Net Income VS EBIT VS OCF VS FCFCELU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • CELU has a Return On Assets of -70.65%. This is in the lower half of the industry: CELU underperforms 62.86% of its industry peers.
Industry RankSector Rank
ROA -70.65%
ROE N/A
ROIC N/A
ROA(3y)-58.77%
ROA(5y)-40.28%
ROE(3y)-375.51%
ROE(5y)-245.63%
ROIC(3y)N/A
ROIC(5y)N/A
CELU Yearly ROA, ROE, ROICCELU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • Looking at the Gross Margin, with a value of 50.61%, CELU is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
  • CELU's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CELU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.74%
GM growth 5YN/A
CELU Yearly Profit, Operating, Gross MarginsCELU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

  • CELU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CELU has more shares outstanding
  • Compared to 5 years ago, CELU has more shares outstanding
  • CELU has a worse debt/assets ratio than last year.
CELU Yearly Shares OutstandingCELU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CELU Yearly Total Debt VS Total AssetsCELU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • CELU has an Altman-Z score of -13.31. This is a bad value and indicates that CELU is not financially healthy and even has some risk of bankruptcy.
  • CELU has a worse Altman-Z score (-13.31) than 77.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.31
ROIC/WACCN/A
WACC6.17%
CELU Yearly LT Debt VS Equity VS FCFCELU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that CELU may have some problems paying its short term obligations.
  • CELU has a Current ratio of 0.16. This is amonst the worse of the industry: CELU underperforms 93.52% of its industry peers.
  • CELU has a Quick Ratio of 0.16. This is a bad value and indicates that CELU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.12, CELU is doing worse than 93.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.12
CELU Yearly Current Assets VS Current LiabilitesCELU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

  • CELU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.42%.
  • The Revenue for CELU has decreased by -15.81% in the past year. This is quite bad
  • Measured over the past years, CELU shows a very strong growth in Revenue. The Revenue has been growing by 36.47% on average per year.
EPS 1Y (TTM)-119.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.97%
Revenue 1Y (TTM)-15.81%
Revenue growth 3Y36.47%
Revenue growth 5YN/A
Sales Q2Q%-43.16%

3.2 Future

  • Based on estimates for the next years, CELU will show a very negative growth in Earnings Per Share. The EPS will decrease by -119.65% on average per year.
  • Based on estimates for the next years, CELU will show a very strong growth in Revenue. The Revenue will grow by 98.27% on average per year.
EPS Next Y-752.63%
EPS Next 2Y-119.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.37%
Revenue Next 2Y49.72%
Revenue Next 3Y144.15%
Revenue Next 5Y98.27%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CELU Yearly Revenue VS EstimatesCELU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CELU Yearly EPS VS EstimatesCELU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • CELU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CELU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELU Price Earnings VS Forward Price EarningsCELU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELU Per share dataCELU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • CELU's earnings are expected to decrease with -119.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-119.65%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • CELU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CELULARITY INC-A

NASDAQ:CELU (1/20/2026, 4:30:00 PM)

1.32

+0.01 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-17
Earnings (Next)05-07
Inst Owners13.47%
Inst Owner Change0%
Ins Owners13.67%
Ins Owner Change10.25%
Market Cap37.40M
Revenue(TTM)40.58M
Net Income(TTM)-80.71M
Analysts82.86
Price Target6.12 (363.64%)
Short Float %2.83%
Short Ratio7.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.58%
Min EPS beat(2)-33.33%
Max EPS beat(2)42.48%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.34
EYN/A
EPS(NY)-2.8
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.43
BVpS-0.71
TBVpS-1.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.61%
FCFM N/A
ROA(3y)-58.77%
ROA(5y)-40.28%
ROE(3y)-375.51%
ROE(5y)-245.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.74%
GM growth 5YN/A
F-Score1
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.12
Altman-Z -13.31
F-Score1
WACC6.17%
ROIC/WACCN/A
Cap/Depr(3y)39.96%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.97%
EPS Next Y-752.63%
EPS Next 2Y-119.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.81%
Revenue growth 3Y36.47%
Revenue growth 5YN/A
Sales Q2Q%-43.16%
Revenue Next Year27.37%
Revenue Next 2Y49.72%
Revenue Next 3Y144.15%
Revenue Next 5Y98.27%
EBIT growth 1Y-21.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.75%
OCF growth 3YN/A
OCF growth 5YN/A

CELULARITY INC-A / CELU FAQ

What is the ChartMill fundamental rating of CELULARITY INC-A (CELU) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CELU.


What is the valuation status of CELULARITY INC-A (CELU) stock?

ChartMill assigns a valuation rating of 0 / 10 to CELULARITY INC-A (CELU). This can be considered as Overvalued.


How profitable is CELULARITY INC-A (CELU) stock?

CELULARITY INC-A (CELU) has a profitability rating of 1 / 10.


What is the financial health of CELULARITY INC-A (CELU) stock?

The financial health rating of CELULARITY INC-A (CELU) is 0 / 10.


What is the earnings growth outlook for CELULARITY INC-A?

The Earnings per Share (EPS) of CELULARITY INC-A (CELU) is expected to decline by -752.63% in the next year.